{"id":2133,"date":"2022-06-14T21:25:18","date_gmt":"2022-06-14T21:25:18","guid":{"rendered":"https:\/\/rosen-testing.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/"},"modified":"2022-07-13T20:22:40","modified_gmt":"2022-07-13T20:22:40","slug":"rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee","status":"publish","type":"post","link":"https:\/\/www.rosen.senate.gov\/es\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/","title":{"rendered":"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee"},"content":{"rendered":"<p style=\"line-height:1.2; text-align:center\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:italic\"><span style=\"text-decoration:none\">Rosen Provisions in FDA Package Will Help Increase Prescription Drug Access&nbsp; and Reduce Medication Costs Through Nonprofit Drug Manufacturing, Strengthen Medical Device Cybersecurity, Improve Health Research for Women<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p style=\"line-height:1.2\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:700\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">WASHINGTON, DC \u2013 <\/span><\/span><\/span><\/span><\/span><\/span><\/span><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">Today, the U.S. Senate Committee on Health, Education, Labor and Pensions advanced the bipartisan <\/span><\/span><\/span><\/span><\/span><\/span><\/span><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:italic\"><span style=\"text-decoration:none\">Food and Drug Administration Safety and Landmark Advancements Act<\/span><\/span><\/span><\/span><\/span><\/span><\/span><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">, which includes four amendments led by Senator Jacky Rosen (D-NV).&nbsp;<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p style=\"line-height:1.2\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">Two of these amendments are based on legislation Senator Rosen introduced earlier this year \u2013 her bipartisan&nbsp; <\/span><\/span><\/span><\/span><\/span><\/span><\/span><a href=\"https:\/\/www.rosen.senate.gov\/es\/rosen-romney-introduce-bipartisan-legislation-advance-more-options-lower-drug-prices\/\" style=\"text-decoration:none\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#1155cc\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:italic\"><span style=\"text-decoration:underline\"><span style=\"-webkit-text-decoration-skip:none\"><span style=\"text-decoration-skip-ink:none\">Advancing Affordable Medicines for Families Act<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\"> with Senator Mitt Romney (R-UT), which would require the Government Accountability Office to issue a report on the effects of nonprofit prescription drugs on bringing down costs; and her bipartisan <\/span><\/span><\/span><\/span><\/span><\/span><\/span><a href=\"https:\/\/www.rosen.senate.gov\/es\/rosen-young-introduce-bipartisan-legislation-strengthen-cybersecurity-medical-devices\/\" style=\"text-decoration:none\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#1155cc\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:italic\"><span style=\"text-decoration:underline\"><span style=\"-webkit-text-decoration-skip:none\"><span style=\"text-decoration-skip-ink:none\">Strengthening Cybersecurity for Medical Devices Act<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:italic\"><span style=\"text-decoration:none\"> <\/span><\/span><\/span><\/span><\/span><\/span><\/span><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">with Senator Todd Young (R-IN), which would require the Food and Drug Administration (FDA) to update its medical device cybersecurity guidance within two years and improve coordination of resources to address cyber threats.&nbsp;<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p style=\"line-height:1.2\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">The other Rosen-led amendments included in this package would require the FDA to hold a public meeting on how nonprofit prescription drug manufacturers can address drug prices and shortages, and require the FDA to update its Women\u2019s Health Research Roadmap, which was last updated in 2015.<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p style=\"line-height:1.2\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">\u201cI\u2019m proud that several of my bills and amendments are moving forward as part of the bipartisan FDA legislative package and are now one step closer to becoming law,\u201d <\/span><\/span><\/span><\/span><\/span><\/span><\/span><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:700\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">dijo el Senador Rosen. <\/span><\/span><\/span><\/span><\/span><\/span><\/span><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"background-color:#ffffff\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">\u201cThese commonsense provisions will increase access to affordable prescription drugs and bring down medication costs through nonprofit drug manufacturing, strengthen medical device cybersecurity, and improve health outcomes for women.\u201d<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p style=\"line-height:1.2; text-align:center\"><span style=\"font-size:13.999999999999998pt; font-variant:normal; white-space:pre-wrap\"><span style=\"font-family:'Times New Roman'\"><span style=\"color:#000000\"><span style=\"font-weight:400\"><span style=\"font-style:normal\"><span style=\"text-decoration:none\">###<\/span><\/span><\/span><\/span><\/span><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Rosen Provisions in FDA Package Will Help Increase Prescription Drug Access&nbsp; and Reduce Medication Costs Through Nonprofit Drug Manufacturing, Strengthen Medical Device Cybersecurity, Improve Health Research for Women WASHINGTON, DC \u2013 Today, the U.S. Senate Committee on Health, Education, Labor and Pensions advanced the bipartisan Food and Drug Administration Safety and Landmark Advancements Act, which [&hellip;]<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[18],"class_list":["post-2133","post","type-post","status-publish","format-standard","hentry","category-press_release","tag-health-care"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee - Jacky Rosen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rosen.senate.gov\/es\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee - Jacky Rosen\" \/>\n<meta property=\"og:description\" content=\"Rosen Provisions in FDA Package Will Help Increase Prescription Drug Access&nbsp; and Reduce Medication Costs Through Nonprofit Drug Manufacturing, Strengthen Medical Device Cybersecurity, Improve Health Research for Women WASHINGTON, DC \u2013 Today, the U.S. Senate Committee on Health, Education, Labor and Pensions advanced the bipartisan Food and Drug Administration Safety and Landmark Advancements Act, which [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rosen.senate.gov\/es\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/\" \/>\n<meta property=\"og:site_name\" content=\"Jacky Rosen\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T21:25:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-13T20:22:40+00:00\" \/>\n<meta name=\"author\" content=\"Reilly Lowery\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reilly Lowery\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/\"},\"author\":{\"name\":\"Reilly Lowery\",\"@id\":\"https:\/\/www.rosen.senate.gov\/#\/schema\/person\/20a03a641934935d4f3d4ef406539869\"},\"headline\":\"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee\",\"datePublished\":\"2022-06-14T21:25:18+00:00\",\"dateModified\":\"2022-07-13T20:22:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/\"},\"wordCount\":279,\"publisher\":{\"@id\":\"https:\/\/www.rosen.senate.gov\/#organization\"},\"keywords\":[\"Health Care\"],\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"es-ES\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/\",\"url\":\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/\",\"name\":\"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee - Jacky Rosen\",\"isPartOf\":{\"@id\":\"https:\/\/www.rosen.senate.gov\/#website\"},\"datePublished\":\"2022-06-14T21:25:18+00:00\",\"dateModified\":\"2022-07-13T20:22:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rosen.senate.gov\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rosen.senate.gov\/#website\",\"url\":\"https:\/\/www.rosen.senate.gov\/\",\"name\":\"Jacky Rosen\",\"description\":\"Senator for Nevada\",\"publisher\":{\"@id\":\"https:\/\/www.rosen.senate.gov\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rosen.senate.gov\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rosen.senate.gov\/#organization\",\"name\":\"United States Senate\",\"url\":\"https:\/\/www.rosen.senate.gov\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\/\/www.rosen.senate.gov\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rosen.senate.gov\/wp-content\/uploads\/2022\/05\/logo-large.png\",\"contentUrl\":\"https:\/\/www.rosen.senate.gov\/wp-content\/uploads\/2022\/05\/logo-large.png\",\"width\":631,\"height\":287,\"caption\":\"United States Senate\"},\"image\":{\"@id\":\"https:\/\/www.rosen.senate.gov\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rosen.senate.gov\/#\/schema\/person\/20a03a641934935d4f3d4ef406539869\",\"name\":\"Reilly Lowery\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\/\/www.rosen.senate.gov\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/255c914696a2d3a7c7933a27408b26fe?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/255c914696a2d3a7c7933a27408b26fe?s=96&d=mm&r=g\",\"caption\":\"Reilly Lowery\"},\"url\":\"https:\/\/www.rosen.senate.gov\/es\/author\/r-lowery\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee - Jacky Rosen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rosen.senate.gov\/es\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/","og_locale":"es_ES","og_type":"article","og_title":"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee - Jacky Rosen","og_description":"Rosen Provisions in FDA Package Will Help Increase Prescription Drug Access&nbsp; and Reduce Medication Costs Through Nonprofit Drug Manufacturing, Strengthen Medical Device Cybersecurity, Improve Health Research for Women WASHINGTON, DC \u2013 Today, the U.S. Senate Committee on Health, Education, Labor and Pensions advanced the bipartisan Food and Drug Administration Safety and Landmark Advancements Act, which [&hellip;]","og_url":"https:\/\/www.rosen.senate.gov\/es\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/","og_site_name":"Jacky Rosen","article_published_time":"2022-06-14T21:25:18+00:00","article_modified_time":"2022-07-13T20:22:40+00:00","author":"Reilly Lowery","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Reilly Lowery","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/#article","isPartOf":{"@id":"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/"},"author":{"name":"Reilly Lowery","@id":"https:\/\/www.rosen.senate.gov\/#\/schema\/person\/20a03a641934935d4f3d4ef406539869"},"headline":"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee","datePublished":"2022-06-14T21:25:18+00:00","dateModified":"2022-07-13T20:22:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/"},"wordCount":279,"publisher":{"@id":"https:\/\/www.rosen.senate.gov\/#organization"},"keywords":["Health Care"],"articleSection":["Press Releases"],"inLanguage":"es-ES"},{"@type":"WebPage","@id":"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/","url":"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/","name":"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee - Jacky Rosen","isPartOf":{"@id":"https:\/\/www.rosen.senate.gov\/#website"},"datePublished":"2022-06-14T21:25:18+00:00","dateModified":"2022-07-13T20:22:40+00:00","breadcrumb":{"@id":"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rosen.senate.gov\/2022\/06\/14\/rosen-led-amendments-included-in-bipartisan-fda-reauthorization-package-advances-out-of-committee\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rosen.senate.gov\/"},{"@type":"ListItem","position":2,"name":"Rosen-Led Amendments Included in Bipartisan FDA Reauthorization Package, Advances Out of Committee"}]},{"@type":"WebSite","@id":"https:\/\/www.rosen.senate.gov\/#website","url":"https:\/\/www.rosen.senate.gov\/","name":"Jacky Rosen","description":"Senator for Nevada","publisher":{"@id":"https:\/\/www.rosen.senate.gov\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rosen.senate.gov\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.rosen.senate.gov\/#organization","name":"United States Senate","url":"https:\/\/www.rosen.senate.gov\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.rosen.senate.gov\/#\/schema\/logo\/image\/","url":"https:\/\/www.rosen.senate.gov\/wp-content\/uploads\/2022\/05\/logo-large.png","contentUrl":"https:\/\/www.rosen.senate.gov\/wp-content\/uploads\/2022\/05\/logo-large.png","width":631,"height":287,"caption":"United States Senate"},"image":{"@id":"https:\/\/www.rosen.senate.gov\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.rosen.senate.gov\/#\/schema\/person\/20a03a641934935d4f3d4ef406539869","name":"Reilly Lowery","image":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.rosen.senate.gov\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/255c914696a2d3a7c7933a27408b26fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/255c914696a2d3a7c7933a27408b26fe?s=96&d=mm&r=g","caption":"Reilly Lowery"},"url":"https:\/\/www.rosen.senate.gov\/es\/author\/r-lowery\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/posts\/2133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/comments?post=2133"}],"version-history":[{"count":1,"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/posts\/2133\/revisions"}],"predecessor-version":[{"id":2204,"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/posts\/2133\/revisions\/2204"}],"wp:attachment":[{"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/media?parent=2133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/categories?post=2133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rosen.senate.gov\/es\/wp-json\/wp\/v2\/tags?post=2133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}